Clinical Trial Details
EORTC-1945
Back to Clinical Trials Database
Stereotactic body radiotherapy in addition to standard of care treatment in patients with oligometastatic rare cancers (OligoRARE): a randomized, phase 3, open-label trial.
| Trial Status | Recruiting |
|---|---|
| Dates |
Date of activation: 10-Jun-2021 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 200 - All Groups: 200 |
| Treatment |
Radiotherapy |
| Study Staff |
Matthias Guckenberger (Study Coordinator) , UniversitaetsSpital Zurich, Zurich Piet Ost (Study Coordinator) , GasthuisZusters Antwerpen - Sint-Augustinus, Wilrijk Jessica Berger (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels Kin Jip Cheung (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels Enrico Clementel (QART Manager) , EORTC Headquarters, Brussels Corneel Coens (Statistician) , EORTC Headquarters, Brussels Coreen Corning (QART Manager) , EORTC Headquarters, Brussels Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Nathalie Elaut (Data Manager) , EORTC Headquarters, Brussels Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels Irina Ghislain (QoL Specialist) , EORTC Headquarters, Brussels Alessandro Gugino (Project Manager) , EORTC Headquarters, Brussels Sylvie Ledroit (Clinical Operations Assistant) , EORTC Headquarters, Brussels Eleni Mandila (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels David Ndah Aki (Junior Clinical Operations Manager) , EORTC Headquarters, Brussels Anouk Neven (Statistician) , EORTC Headquarters, Brussels Sara Nicolas (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Delphine Sartori (Study Designer) , EORTC Headquarters, Brussels Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Christine de Balincourt (Lead CRA) , EORTC Headquarters, Brussels |
| Type of cancer |
Head and Neck Melanoma Soft Tissue and Bone Sarcoma Solid Tumors, Unspecified Thyroid Renal |
| Participating groups | EORTC Radiation Oncology Group |
| Recruiting centers |
Centre Oscar Lambret (Lille, France) GasthuisZusters Antwerpen - Sint-Augustinus (Wilrijk, Belgium) Gustave Roussy (Villejuif, France) Inselspital (Bern, Switzerland) UniversitaetsSpital Zurich (Zurich, Switzerland) Universitair Ziekenhuis Gent (Gent, Belgium) |
| Centers to be activated |
IRCCS - Fondazione G. Pascale (Napoli, Italy) Institut Bergonie (Bordeaux, France) Istituto Europeo di Oncologia (Milano, Italy) Kliniken Maria Hilf GmbH (Moenchengladbach, Germany) Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) UHB-Queen Elisabeth Medical Centre (Birmingham, United Kingdom) UKE - University Cancer Center (Hamburg, Germany) UniversitaetsMedizin Mannheim (Mannheim, Germany) |
| Protocol summary | http://clinicaltrials.gov/ct/show/NCT04498767 |
| NCT number | NCT04498767 |
| Financial Support |
EORTC HQ Anticancer Fund Rising Tide Foundation for Clinical Cancer Research |
